ECTE Considered to be “Undervalued”
Hello, Traders!
Hopefully everyone has had an opportunity to begin researching the huge upside prospects of Echo Therapeutics, Inc. (OTCBB: ECTE).
The symbol could be tremendously popular amongst investors for both fundamental and technical reasons.
And…readers of this newsletter are among the FIRST to hear about ECTE on a wide scale basis.
So, if you there is a stock that you should be considering entering now… consider loading up on ECTE!
My Top 4 Favorite Factors About ECTE
#1. ECTE’s trans-dermal system is the ONLY needle-free continuous blood glucose monitoring (CBGM) system in the world. So, ECTE’s Glucose Monitoring System could virtually eliminate the pain that diabetics experience when testing their glucose levels. That means no more needles for this purpose!
#2. ECTE Could be a Buyout Candidate. Because other major pharmaceutical companies do not have the technology to monitor glucose levels, and the number of Diabetics worldwide, have grown significantly, ECTE presents itself as a potentially top selection from Diabetic consumers. I’m not the only person that has stated that the Company is positioned nicely as a potential acquisition target. Even the CEO admited that a merger or acquisition was a posibility during an interview that is now available at www.stockgoodies.com.
#3. ECTE Could Move to a Higher Exchange. According to the Corporate Profile (found at http://brettmaas.com/) one of the "12 Month Milestones" ECTE has is to obtain a listing for the AMEX or Nasdaq. And, in order to achieve that goal the symbol needs to be trading at higher levels…which means the company could be motivated to not dilute their market…which means share prices could SURGE!
#4. ECTE Likely to Obtain FDA Approval. When asked where he thought the company would be 5 years from now, the CEO stated that if not acquired or merged into a larger company – which are distinct possibilities – ECTE would possibly have 3 FDA-approved medical device products on the market. I believe this could be a huge catalyst for a MASSIVELY increased sales stream and help transform it into a major medical device supplier!
———————————————————————————-
Below is a blog that I found which discusses some of the Investment Highlights pertaining to ECTE.
———————————————————————–
ECTE could be a great trade idea so keep the symbol on your trading platform and watch it closely.
ECTE has some of the most solid fundamental and technical factors relative to most other stocks I’ve introduced… and I expect that many traders strongly believe this will be a profitable trade idea!
Best Regards,
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. ****************************************************************************************************************** The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: The SuperHotPennyStocks employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://www.superhotpennystocks.com/disclaimer Release of Liability: Through use of this website viewing or using you agree to hold SuperHotPennyStocks, its operators owners and employees harmless and to compltely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or
otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SuperHotPennyStocks’s affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SuperHotPennyStocks encourages readers and investors to supplement the information in these reports with independent research and other pro advice. SuperHotPennyStocks has agreed to be compensated one hundred fifty thousand dollars for a one month investor awareness program by a third party for ECTE. All information on featured companies is provided by the companies profiled, or is available from public sources and SuperHotPennyStocks makes no representations,
warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to or sell any securities. Any claims or Statements should be deemed apocryphal. SuperHotPennyStocks, nor any of its affiliates are not registered investment advisors or a broker dealers.
otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SuperHotPennyStocks’s affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SuperHotPennyStocks encourages readers and investors to supplement the information in these reports with independent research and other pro advice. SuperHotPennyStocks has agreed to be compensated one hundred fifty thousand dollars for a one month investor awareness program by a third party for ECTE. All information on featured companies is provided by the companies profiled, or is available from public sources and SuperHotPennyStocks makes no representations,
warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to or sell any securities. Any claims or Statements should be deemed apocryphal. SuperHotPennyStocks, nor any of its affiliates are not registered investment advisors or a broker dealers.
|
|
